Teva ADR: income, profit beat forecasts in Q2

%2B1,99% to Add/clean TEVA from a portfolio to Add in the Position Add a Position list it is successfully added: %2B to Add other position to Close Investing.com - Teva Pharmaceutical Industries Ltd ADR (NYSE: TEVA) issued on Wednesday the report with results in the second quarter which surpassed analysts. The indicator of the income exceeded forecasts. Company declared an earning per share of $0,56, the income made of $3,9B. The analysts interrogated by Investing.com, assumed in forecasts that the earning per share will make $0,53, and the total income will make of $3,72B Teva Pharmaceutical Industries Ltd ADR follows the general trend of companies sectors...